Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7072)
All Articles published online
|
Publishing Process of This Article
|
Sep 8, 2016 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chao CCK. Inhibition of apoptosis by oncogenic hepatitis B virus X protein: Implications for the treatment of hepatocellular carcinoma. World J Hepatol 2016; 8(25): 1061-1066 [PMID: 27660672 DOI: 10.4254/wjh.v8.i25.1061] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i25/1061.htm |
| Number | Citing Articles |
| 1 |
Sha Liu, Fang Huang, Guoqing Ru, Yigang Wang, Bixiang Zhang, Xiaoping Chen, Liang Chu. Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.902820
|
| 2 |
Shu-Xiang Wu, Wan-Nan Chen, Zhen-Tang Jing, Wei Liu, Xin-Jian Lin, Xu Lin, J.-H. James Ou. Hepatitis B Spliced Protein (HBSP) Suppresses Fas-Mediated Hepatocyte Apoptosis via Activation of PI3K/Akt Signaling. Journal of Virology 2018; 92(23) doi: 10.1128/JVI.01273-18
|
| 3 |
Yun Feng, Fang Li, Jing Yan, Xianli Guo, Fenghui Wang, Haiyan Shi, Juan Du, Huahua Zhang, Yi Gao, Dan Li, Yan Yao, Weihong Hu, Jiaqi Han, Mengjie Zhang, Ruxin Ding, Xiaofei Wang, Chen Huang, Jing Zhang. Pan-cancer analysis and experiments with cell lines reveal that the slightly elevated expression of DLGAP5 is involved in clear cell renal cell carcinoma progression. Life Sciences 2021; 287: 120056 doi: 10.1016/j.lfs.2021.120056
|
| 4 |
Jun Wu, Meihong Han, Jia Li, Xiaoli Yang, Dongliang Yang. Hepatitis B Virus Infection. Advances in Experimental Medicine and Biology 2020; 1179: 71 doi: 10.1007/978-981-13-9151-4_4
|
| 5 |
Shouhua Zhang, Nuoya Li, Yanling Sheng, Wen Chen, Qiangliang Ma, Xin Yu, Jianping Lian, Junquan Zeng, Yipeng Yang, Jinlong Yan. Hepatitis B virus induces sorafenib resistance in liver cancer via upregulation of cIAP2 expression. Infectious Agents and Cancer 2021; 16(1) doi: 10.1186/s13027-021-00359-2
|
| 6 |
Nikolaos D. Karakousis, Alkistis Papatheodoridi, Antonios Chatzigeorgiou, George Papatheodoridis. Cellular senescence and hepatitis B‐related hepatocellular carcinoma: An intriguing link. Liver International 2020; 40(12): 2917 doi: 10.1111/liv.14659
|
| 7 |
Liping Ai, Qing-Qing Liu, Yize Li, Yuanyuan Wang, Hong-Mei Zhang. The Role of HBx Protein in Diseases Beyond the Liver. Infection and Drug Resistance 2023; : 3225 doi: 10.2147/IDR.S405316
|
| 8 |
A. V. Zamaraev, B. Zhivotovsky, G. S. Kopeina. Viral Infections: Negative Regulators of Apoptosis and Oncogenic Factors. Biochemistry (Moscow) 2020; 85(10): 1191 doi: 10.1134/S0006297920100077
|
| 9 |
Chutchai Piewbang, Wichan Dankaona, Panida Poonsin, Jakarwan Yostawonkul, Sitthichok Lacharoje, Sirintra Sirivisoot, Tanit Kasantikul, Padet Tummaruk, Somporn Techangamsuwan. Domestic cat hepadnavirus associated with hepatopathy in cats: A retrospective study. Journal of Veterinary Internal Medicine 2022; 36(5): 1648 doi: 10.1111/jvim.16525
|
| 10 |
Yong Gao, Juan Gu, Yueping Wang, Decai Fu, Wensheng Zhang, Guofu Zheng, Xuedong Wang. Hepatitis B virus X protein boosts hepatocellular carcinoma progression by downregulating microRNA-137. Pathology - Research and Practice 2020; 216(6): 152981 doi: 10.1016/j.prp.2020.152981
|
| 11 |
Shaoli Lin, Yan-Jin Zhang. Interference of Apoptosis by Hepatitis B Virus. Viruses 2017; 9(8): 230 doi: 10.3390/v9080230
|
| 12 |
Shringar Rao, Tanvir Hossain, Tokameh Mahmoudi. 3D human liver organoids: An in vitro platform to investigate HBV infection, replication and liver tumorigenesis. Cancer Letters 2021; 506: 35 doi: 10.1016/j.canlet.2021.02.024
|
| 13 |
Dharmendra Kashyap, Nidhi Varshney, Hamendra Singh Parmar, Hem Chandra Jha. Gankyrin: At the crossroads of cancer diagnosis, disease prognosis, and development of efficient cancer therapeutics. Advances in Cancer Biology - Metastasis 2022; 4: 100023 doi: 10.1016/j.adcanc.2021.100023
|
| 14 |
Pei‐song Bai, Nan Xia, Hong Sun, Ying Kong. Pleiotrophin, a target of miR‐384, promotes proliferation, metastasis and lipogenesis in HBV‐related hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 2017; 21(11): 3023 doi: 10.1111/jcmm.13213
|